Evaluation and Implementation

Welcome to the Evaluation & Implementation theme. The aim of our research work is three fold; to improve the delivery of health research data to researchers and clinicians; introduce measures to assess the quality of life improvements to patients who are taking part in experimental clinical trials; and finally to understand the ethical, social and legal implications that result from new discoveries and ensure that advances in biomedical research benefit patients and the wider population.

To do that we need to build capacity in ethics, law, social sciences, biostatistics, trials, public health and knowledge brokerage; and to strengthen links with patient and public organisations.

The theme will deliver it’s expertise through three key areas –

  • Integration of health data across different health and social care sectors
  • Evaluating quality of life measures in experimental trials
  • Examining the social and ethical implications of implementation of new technologies to ensure that there is a smooth transition from innovation to final product. Play the video to hear Carol talk about the their approach to research.

 

We will then be able to provide expertise in evaluating the cost - effectiveness of clinical trials; examine the ethical and social implications of changes to health care delivery; and develop IT systems which will provide accurate research data to clinicians who are evaluating differing drugs or therapies.

Spearheading this work are research teams within the Cambridge Institute of Public Health, housing the Data4Health team,  the Cambridge Centre for Health Services Research, the PHG Foundation. All are based within Cambridge Biomedical Research Centre campus and will work closely with theme leaders and research groups across the BRC and within the University of Cambridge.

The strength and depth of scientific research here in Cambridge is world renowned and is vital for the development of a healthy nation and economy that we capitalise on this research and deliver real benefits to the UK and worldwide population.

Professor Carol Brayne